Dr. Maggie A. Kuhn, MD

Dr. Kuhn practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Kuhn's NPI, 1265638795, was assigned on June 22, 2007. Dr. Kuhn graduated from New York University School of Medicine in 2007. Dr. Kuhn holds California license A118415.

Dr. Kuhn's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Kuhn's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Kuhn to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kuhn practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Kuhn's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Kuhn is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Kuhn's licenses on file in 2 states: California and New York.

Dmand AI lists chronic nasal allergies, endoscopic sinus surgery and larynx and vocal cord disease among the conditions Dr. Kuhn treats.

CMS data shows 1,368 Medicare services from Dr. Kuhn across 16 procedure codes in 2024, for 563 Medicare patients. Medicare paid $86,640 for them.

CMS counts 563 Medicare patients who saw Dr. Kuhn in 2024. The largest group is 65 to 74, with 225 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kuhn's median patient age at 65, with 57% women.

In 2024, Dr. Kuhn wrote 150 Medicare Part D claims for 56 patients. 95% of them were for generic drugs. CMS names the drug for 117 of them, across 6 drugs with 11 or more claims each, at $2,028 in total drug cost. In 2023, CMS named 100 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kuhn for performance year 2024, reported as part of a group. Dr. Kuhn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kuhn as offering telehealth. CMS counts 27 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kuhn, more than 54% of the clinicians it reports for that procedure.

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 54 papers to Dr. Kuhn, published from 2011 to 2025. 2017 was the busiest year, with 8. The most frequent topics are Deglutition Disorders, Fluoroscopy and Deglutition. Dr. Kuhn has published most often in Laryngoscope. Dr. Kuhn's most frequent co-authors are Peter Charles Belafsky, MD, PhD, Daniel John Cates, MD and Naren Natraj Venkatesan, MD.

Dmand AI links Dr. Kuhn to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Deglutition Disorders and Pharyngeal Diseases.

CMS Open Payments shows 11 general payments to Dr. Kuhn from 10 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. DePuy Synthes Sales Inc. paid the most, $179.

Dmand AI lists 1 award for Dr. Kuhn.

Dr. Kuhn graduated from New York University School of Medicine in 2007. Dr. Kuhn is a member of NHS.

Dr. Kuhn is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.